Aerpio pharmaceuticals, inc. (ARPO)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities:
Net and comprehensive loss

-3,918

-4,446

-4,647

-5,683

-8,492

-8,518

11,537

-5,989

-7,425

-6,235

-4,649

-5,520

-4,995

-3,517

-4,885

-8,573

-6

-17,050

-6

-7

-5

-11

-6

-6

-5

-9

-6

-6

-6

-9

-6

-6

-5

-8

-6

-6

-5

Adjustments to reconcile net and comprehensive loss to net cash used in operating activities:
Depreciation

15

22

20

20

12

11

11

11

12

11

12

13

13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

327

-786

645

604

621

667

806

877

1,079

255

127

111

155

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Consulting expenses related to warrants

62

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

0

0

0

75

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense related to convertible note conversion

-

-

-

-

-

-

-

-

-

0

0

0

204

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Prepaid research and development contracts

-82

-227

170

27

-413

417

-91

-19

135

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current assets

-167

-141

612

-271

-79

-279

681

-184

75

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

28

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and current other assets

-

-

-

-

-

-

-

-

-

-

-

-

337

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and other current liabilities

-675

-

1

-331

-1,713

-

679

-657

30

-

729

-1,113

982

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

37,460

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5

0

0

1

0

4

-1

-2

-4

-0

5

-1

-1

-1

5

-1

Increase in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

-

0

-8

7

-8

2

7

0

-0

0

-6

4

1

0

-3

0

0

0

-1

1

Increase in accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-

-

2

1

1

1

1

1

1

1

1

1

1

1

1

1

0

0

0

0

Increase in accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5

-

0

0

-5

5

0

-4

1

2

0

1

-4

4

0

0

-4

-

-

-

-

Increase (decrease) in accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

Net cash used in operating activities

-3,939

-4,865

-4,763

-5,146

-9,078

-6,184

-6,221

13,112

-6,513

-

-

-

-

-

-

-

-5

-17,865

-3

-13

-1

-12

-1

-1

-0

-4

-8

-9

-1

-0

-3

-14

-5

-2

-3

-15

-2

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-3,929

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investing activities:
Purchase of furniture and equipment

-

-0

4

119

113

8

20

0

8

2

0

4

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

0

-4

-119

-113

-8

-20

0

-8

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing activities:
Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

0

53

1

21

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuances of convertible notes

-

-

-

-

-

-

-

-

-

0

0

0

297

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on notes payable, stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

Payments on notes payable, stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Proceeds from sale of common stock

-

-

-

-

-

-

-

-

-

0

0

0

40,247

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

Cash paid in connection with the sale of common stock

-

-

-

-

-

-

-

-

-

0

0

0

3,084

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from notes payable, stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

20

0

15

0

0

0

0

25

0

-

-

-

25

0

0

0

0

Net cash provided by financing activities

-

-

-

-

-

0

6,266

41,906

21

-

-

-

-

-

-

-

0

-17

0

0

20

0

15

0

0

0

0

25

0

0

0

0

25

0

0

0

0

Net decrease in cash and cash equivalents

-3,939

-

-

-

-9,191

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (decrease) increase in cash and cash equivalents

-

-

-

-

-

-

-

55,019

-6,500

-4,564

-4,019

-6,291

33,529

301

-294

-3,536

-5

-17,923

-3

-13

18

-12

13

-1

-0

-4

-8

15

-1

-0

-3

-14

19

-2

-3

-15

-2

Conversion of redeemable convertible preferred stock into common stock

-

-

-

-

-

-

-

-

-

0

0

0

74,701

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of convertible notes and accrued interest into common stock

-

-

-

-

-

-

-

-

-

0

0

0

13,447

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

0

0

0

943

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-